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ed March 5, 2013.his study sought to ascertain causes of death and the incidence of percutaneous coronary intervention (PCI)-related
mortality within 30 days.Background Public reporting of 30-day mortality after PCI without clearly identifying the cause may result in operator risk
avoidance and affect hospital reputation and reimbursements. Death certiﬁcates, utilized by previous reports, have
poor correlation with actual cause of death and may be inadequate for public reporting.Methods All patients who died within 30 days of a PCI from January 2009 to April 2011 at a tertiary care center were
included. Causes of death were identiﬁed through detailed chart review using Academic Research Consortium
consensus guidelines and compared with reported death certiﬁcates. The causes of death were divided into cardiac
and noncardiac and PCI and non–PCI-related categories.Results Of the 4,078 PCI, 81 deaths (2%) occurred within 30 days. Of these, 58% died of cardiac and 42% of noncardiac
causes. However, only 42% of 30-day deaths were attributed to PCI-related complications. Patients with non–PCI-
related, compared with PCI-related, death presented with a higher incidence of cardiogenic shock (15 of 47 [32%]
vs. 2 of 34 [6%]; p < 0.01) and cardiac arrest (19 of 47 [40%] vs. 1 of 34 [3%]; p < 0.01). Death certiﬁcates had
only 58% accuracy (95% conﬁdence interval: 45% to 72%) for classifying patients as experiencing cardiac versus
noncardiac death.Conclusions Less than one-half of 30-day deaths are attributed to a PCI-related complication. Death certiﬁcates are inaccurate
and do not report PCI-related deaths, which may represent a better marker of PCI quality. (J Am Coll Cardiol
2013;62:409–15) ª 2013 by the American College of Cardiology FoundationPublic reporting of outcomes after percutaneous coronary
intervention (PCI) is likely to be made standard practice as
advocated by the Centers forMedicare andMedicaid Services
(1). Implementation of this policy will lead to several
important consequences. First, Medicare and Medicaid
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2012; revised manuscript received February 15,reporting and disclosure of these data will affect the credibility
and reputation of a healthcare provider, hopefully helping
patients to make informed decisions about their healthcare
choices (3). Finally, analysis of the outcomes data will be
useful in determining appropriateness and hence cost-
effectiveness of performing these procedures (4).See page 416Whereas publicly reported outcomes could be considered
surrogate markers for healthcare quality, thus far, such
disclosures have resulted in mixed reactions from healthcare
providers (5–7). In New York and Massachusetts where
PCI outcomes were ﬁrst publicly reported, a strong selection
bias toward avoidance of PCI in high-risk patients was
subsequently described (8,9). Because of these potentially
adverse consequences, many have advocated the importance
Table 1 Deﬁnitions of Non
Cause of Death
Infectious Death from
conferen
Neurological* Death due
Pulmonary Death afte
Gastrointestinal Death from
antiplate
Hemato-oncological Death from
or withd
Renaly Death due
*In patients with cardiac arrest, death was
patient was also required to have a success
or if no such data were available, cause of
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ARC = Academic Research
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410of reporting risk-adjusted out-
comes, which try to take into
account the severity of underlying
illnesses (10–14). However, PCI-
associated deaths are exceedingly
rare, and although risk models are
helpful for the majority of pa-
tients, their ability to predict the
risk of death in very small sub-
groups (such as PCI patients at
very high risk of death) is poor
(11). Moreover, the majority ofthese risk scores were derived from mortality data obtained
through death certiﬁcates, which are often inaccurate in
precisely identifying the cause of death (15–17). Another
limitation is lack of data on PCI versus non–PCI-related
mortality, which may be a better measure of operator
performance and PCI quality. For these reasons, we con-
ducted a detailed chart review to identify the causes of 30-day
post-PCI deaths employing standard deﬁnitions from glob-
ally recognized Academic Research Consortium (ARC)
consensus guidelines (18,19).Methods
Study population. All patients who underwent PCI from
January 2009 to April 2011 at a single tertiary care center were
identiﬁed through the institutional review board–approved
institutional PCI registry. Baseline characteristics, cardiac
history and risk factors, medications, other chronic medical
illnesses, and angiographic and procedural data were
prospectively obtained and recorded. Thirty-day deaths after
PCI were identiﬁed after querying the Social Security Death
Index. Circumstances surrounding death such as the decision
to withdraw care and site of death were obtained. Medical
charts were retrospectively reviewed for cause of death
together by 2 clinicians (B.A. and M.H.S.) using standard
ARC deﬁnitions to prevent any bias. Cause of death by chart
review was compared with death certiﬁcates when available.
Deﬁnitions. Cardiogenic shock on presentation was de-
ﬁned as systolic blood pressure persistently <90 mm Hg or
the need for inotropic support or intra-aortic ballooncardiac Causes of Death
severe sepsis or septic shock as deﬁned by the Soc
ce guidelines (19).
to anoxic brain injury prior to PCI, cerebrovascular ac
r worsening respiratory status due to primary lung pa
massive gastrointestinal bleeding, as complication o
let therapy.
life-threatening hemorrhage (except gastrointestinal
rawal of care due to concerns regarding poor prognos
to complication of renal failure such as ﬂuid overload
adjudicated to be neurological only if neurological dysfuncti
ful PCI with restoration of stable cardiac pump function as det
death was considered to be cardiac. yExcluding patients withpumping to maintain systolic blood pressure >90 mm Hg, in
the presence of adequate left ventricular ﬁlling pressure and
systemic hypoperfusion (18). Neurological dysfunction was
deﬁned as Glasgow Coma Scale score <9 or unresponsive-
ness to any stimuli with absence of brain stem reﬂexes (in
cases were the Glasgow Coma Scale was not checked).
Cause of death was deﬁned as the precipitating factor for
the patient’s demise, independent of the presenting medical
problem on admission (20). There were 19 deaths after initial
discharge of whom 8 died after readmission. An attempt to
obtain information regarding 11 out-of-hospital deaths was
made through a nurse phone call to the patients’ families. Of
these, no record could be obtained, and the families could
not be reached for 5 patients.
The causes of death were divided into cardiac- and
noncardiac-related and PCI- and non–PCI-related cate-
gories. Cardiac death was deﬁned as any death due to prox-
imate cardiac cause (such as myocardial infarction, low output
failure, or fatal arrhythmia), unwitnessed death, death from
unknown cause, and all procedure-related deaths, including
those related to concomitant treatment. Noncardiac causes
were divided into respiratory, infectious, neurological,
gastrointestinal (GI), renal and hemato-oncological cate-
gories (Table 1). All deaths were considered cardiac unless an
unequivocal noncardiac cause could be established. In cases
without reasonable clinical evidence toward one or the other,
death was determined noncardiac only if stable cardiac pump
function was determined by pulmonary artery catheterization.
PCI-related death was deﬁned as death from complica-
tion of procedure such as vascular dissection, aneurysm,
perforation, bleeding, renal failure, and deﬁnite or probable
stent thrombosis. Stent thrombosis was deﬁned as “deﬁnite”
after angiographic conﬁrmation or “probable” in case of any
unexplained death within 30 days or any myocardial in-
farction that was related to documented acute ischemia in
the territory of the implanted stent (18). Any bleeding was
considered PCI-related if it occurred within 72 h of the
procedure, and death from such bleeding was labeled as
a complication of PCI (21).
Statistical analysis. PCI and non–PCI-related deaths were
compared with regard to demographics, past medical his-
tory, presenting history, indication for procedure, and theDeﬁnition
iety of Critical Care Medicine/American College of Chest Physicians consensus
cident, or brain death from any cause.
thology including acute respiratory distress syndrome.
f liver disease, cancer, or gastrointestinal perforation not related to dual
and intracranial hemorrhage) or due to an advanced cancer, its complication,
is associated with cancer.
, acidosis, and electrolyte disturbances.
on was documented prior to the start of percutaneous coronary intervention (PCI). In addition, the
ermined by either a pulmonary artery catheterization or lack of inotropic support. In equivocal cases
contrast-induced nephropathy from iodinated contrast administered during PCI.
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411site of death. Continuous variables were presented as mean 
SD or median with interquartile range, and categorical
variables were presented as percentage affected. Fisher exact
test for categorical variables and Wilcoxon rank order test for
continuous variables were used to compare differences in
categories. Accuracy, sensitivity, and speciﬁcity of death
certiﬁcates for classifying patients as experiencing cardiac
versus noncardiac death were calculated after assuming chart
review diagnosis as the gold standard. All tests were 2-tailed
and a p value <0.05 was considered signiﬁcant.
Results
A total of 4,078 PCI (including emergent, urgent, elective,
and salvage) were performed from January 2009 to April
2011. All-cause mortality within 30 days of PCI was 2%
(n ¼ 81), and a cause of death could be established in 76
patients. Death records were not available for 5 patients who
died after hospital discharge. Forty-seven patients (58%) died
from cardiac and 34 (42%) from noncardiac causes (Fig. 1).
Fifty-three patients presented with cardiogenic shock and
underwent PCI, of these, 17 (32%) died within 30 days.
Similarly, mortality for patients presenting with ST-segment
elevation myocardial infarction (STEMI) and undergoing
PCI was 7% (37 of 535 patients), whereas that for patients
presenting with cardiac arrest was 41% (20 of 49 patients).
Of the noncardiac causes of death, complications of
infection such as septic shock or severe sepsis were most
common. About one-half of these had evidence of active
infection prior to PCI (as demonstrated by a positive blood
culture within 72 h of PCI). Death due to a neurologicalFigure 1 Etiology of 30-Day Mortality After PCI Based on Chart Revi
Etiology of death (in percentage) divided into percutaneous coronary intervention (PCI)-rela
hemato-oncological causes.cause was the next most prevalent noncardiac cause (Fig. 1).
The majority of these were from withdrawal of care after
anoxic brain injury, which had likely occurred prior to PCI
as a result of cardiac arrest or shock.
Of the cardiac deaths, 34 patients died from PCI-related
complications and 13 from non–PCI-related cardiac com-
plications mainly related to pump dysfunction. The majority
of PCI-related deaths were attributed to probable stent
thrombosis (Fig. 2). Four patients died from fatal bleeding
within 72 h of PCI with 2 cases of intracranial hemorrhage
and 1 case each of massive GI bleeding and retroperitoneal
hemorrhage. Lastly, 3 patients died from coronary dissection,
and 2 died from complications of renal failure attributed to
iodinated contrast administered with the procedure. Both
patients had documented stable renal function prior to PCI.
Baseline and angiographic characteristics of PCI and
non–PCI-related deaths (including noncardiac) are shown
in Table 2. Both groups were comparable in terms of
baseline demographics and pre-existing cardiac risk factors.
However, patients who died from a non–PCI-related death
presented more often with cardiogenic shock (p < 0.01) or
cardiac arrest (p < 0.01) and had a higher prevalence of New
York Heart Association functional class IV heart failure
(p < 0.01) prior to hospitalization (Table 2). In addition,
non–PCI-related deaths occurred more often during index
admission than did PCI-related deaths (p < 0.01) (Fig. 3).
Death certiﬁcates were available in 53 patients. There was
poor correlation between death certiﬁcates and chart review
for classifying death into cardiac versus noncardiac death.
When compared with chart review, death certiﬁcates had
a sensitivity of 69% (95% conﬁdence interval [CI]: 52% toew
ted, cardiac non–PCI-related, neurological, infection, pulmonary, gastrointestinal, and
Figure 2 Etiology of 30-Day Mortality Due to PCI-Related Complications Based on Chart Review
Speciﬁc etiology of death (in percentage) from complication of percutaneous coronary interventions (PCI) divided into bleeding, renal failure, coronary dissection, and stent
thrombosis. Death from stent thrombosis is further divided into death from cardiac arrest during admission, cardiac arrest after discharge, and unknown cause.
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41286%), speciﬁcity of 46% (95% CI: 26% to 66%), and an
accuracy of 58% (95% CI: 45% to 72%) (Fig. 4).
Discussion
This is the ﬁrst report in the past decade identifying etiology of
death within the critical 30-day period after a PCI from
a thorough chart review and using standardARCguidelines. In
our cohort, cardiac causes contributed to 58% of all deaths after
PCI, and only 42%were attributed to complications associated
with the procedure. Even this was perhaps an overestimation
because all unexplained deaths within 30 days of PCI were
considered probable stent thrombosis in this analysis. This is in
contrast to previously reported data using death certiﬁcates
where a much higher proportion of deaths were attributed to
cardiac- and PCI-related complications (15,22–24). The
highest-risk patients (cardiogenic shock and cardiac arrest)
whomay potentially experience risk avoidance rarely died from
a PCI-related complication. In addition, a poor correlation
between cause of death determined by chart review and that
reported by death certiﬁcates was observed. These results
highlight the limitations of 30-day mortality reporting when
death certiﬁcates are used and emphasize the need for identi-
fying PCI-related deaths rather than cardiac deaths alone.
Mortality is an outcome measure that is most likely to
inﬂuence reimbursements and the public reputation of an
institution.Therefore, it is important to classify causes of death
into categories that truly reﬂect a physician and an institution’s
competence and acts as an indicator of performance. Most
PCI and acute coronary syndrome outcome studies classifydeaths as from either cardiac or noncardiac causes rather than
PCI- or non–PCI-related causes. Such classiﬁcation may be
misleading as institutional reporting of low cardiac death
rates may be a result of risk avoidance (refusing PCI in high-
risk patients such as those with STEMI, cardiogenic shock,
or cardiac arrest) or a result of referral of such patients to
different centers (6,7,25). We propose classifying post-PCI
deaths as PCI- or non–PCI-related, which better represents
quality of PCI and operator performance.
The overall mortality after PCI for a given provider is
greatly inﬂuenced by the severity of a patient’s illness and
presentation. This is currently determined by several risk
scores, but there remain concerns among interventionalists
regarding the validity of these to accurately predict mortality
after PCI (26). Because the expected in-hospital mortality
after PCI is very low, this concern is especially relevant to the
patients at the highest risk of death (27). Lack of trust in the
current risk prediction models has led to avoidance of high-
risk cases by clinicians in centers where outcome reporting
was made mandatory. This was evident from the outcomes
data published from the New York State PCI registry, which
revealed that in-hospital mortality after PCI had declined
from 0.90% in 1997 (28) to 0.58% in 2003 (29), a reduction of
36%. Although this might be superﬁcially interpreted as due
to a signiﬁcant quality improvement, closer analysis revealed
a simultaneous trend toward avoidance of PCI in patients
presenting with cardiogenic shock (8). Similar results were
observed in data from the Massachusetts PCI registry when
outcome reporting became mandatory in that state (27).
A “compassionate use” variable was proposed to account for
Table 2 Patient Characteristics According to Etiology of Death by Chart Review
PCI-Related Death
(n ¼ 34)
Non–PCI-Related Death
(n ¼ 47) p Value
Baseline characteristics and cardiac risk factors
Age, yrs 69  14 71  11 0.43
Male 19 (56) 28 (60) 0.82
Previous myocardial infarction 20 (59) 32 (68) 0.48
Previous percutaneous coronary intervention 14 (41) 15 (32) 0.48
Previous coronary artery bypass graft 3 (9) 9 (19) 0.23
Diabetes mellitus 14 (41) 24 (51) 0.50
History of renal failure 5 (15) 11 (23) 0.41
Current smoker 4 (12) 11 (23) 0.25
Peripheral vascular disease 8 (24) 9 (19) 0.78
Cardiac characteristics at admission
Ejection fraction 39  15 36  15 0.58
STEMI 13 (38) 24 (51) 0.27
Non–STEMI 5 (15) 14 (30) 0.18
Unstable angina 5 (15) 2 (4) 0.12
Cardiogenic shock 2 (6) 15 (32) <0.01
Cardiac arrest 1 (3) 19 (40) <0.01
Other comorbid conditions
History of stroke/transient ischemic attack 5 (15) 11 (23) 0.41
Neurological dysfunction 3 (9) 14 (30) 0.03
Infection pre-procedure 1 (3) 6 (13) 0.23
Dementia 4 (12) 0 (0) 0.03
Outside hospital transfer 20 (59) 25 (53) 0.66
New York Heart Association functional class
I 1 (3) 3 (6) 0.64
II 4 (12) 2 (4) 0.23
III 11 (32) 3 (6) <0.01
IV 18 (53) 39 (83) <0.01
Number of diseased vessels
1 22 (65) 31 (66) 1.00
2 8 (24) 11 (23) 1.00
3 4 (12) 5 (11) 1.00
Stent placed 31 (91) 44 (94) 0.69
Use of intra-aortic balloon pump 8 (24) 12 (26) 1.00
Creatinine pre-procedure, mg/dl 1.3 (0.9–1.6) 1.2 (1.0–1.7) 0.79
Hemoglobin pre-procedure, g/dl 11  2 11  3 0.33
Values are mean  SD, n (%), or median (interquartile range).
PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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413patients with highest risk, whereas other investigators
proposed that perhaps patients presenting in cardiogenic
shock and cardiac arrest should be omitted from mandatory
reporting (10). According to Massachusetts Data Analysis
Center deﬁnitions, 22% (n¼ 18) of our patients who diedmet
the compassionate use criteria; however, of these, only 4 had
PCI-related mortality. Among the remaining 78% (n ¼ 63),
52% (33 of 63) died of non–PCI-related mortality, high-
lighting the current limitation of excluding only those patients
meeting the compassionate use deﬁnition.
Of the patients who died in our cohort, 58% (47 of 81
patients) presented with STEMI, cardiogenic shock, or
cardiac arrest. This highlights the high-risk nature of many
patients undergoing PCI who could potentially be considered
emergent or salvage. Emergent procedures are not currently
excluded from public reporting, and the current NCDR(National Cardiovascular Data Registry) deﬁnition of salvage
PCI would not incorporate many of these patients (21). In our
cohort, the majority of these patients did not die of a PCI-
related complication, perhaps indicating that such a presenta-
tion should not be a deterrent to PCI if otherwise indicated.
Although these patients contribute signiﬁcantly toward overall
mortality, they are also individuals who are likely to beneﬁt
the most from PCI (30,31). Whereas some investigators have
suggested excluding such patients from public reporting, using
PCI- and non–PCI-related outcomes will allow public trans-
parency yet avoid risk avoidance in these high-risk patients.
The main limitation of previous publications assessing
PCI-associated mortality has been the sole reliance on death
certiﬁcates that are well documented to be susceptible to
serious biases and are often inaccurate (32–36). They often
fail to capture other acute medical events during the course
Figure 3
Site of Death Among PCI and
Non–PCI-Related Categories
Site of death in percutaneous coronary intervention (PCI) and non–PCI-related
death categories divided into those during index admission or after discharge
(in percentage). Non–PCI-related death occurred more often during index
admission than PCI-related deaths did (p < 0.01).
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414of the hospital stay, which ultimately contributed to the
death of the patient, thereby often mislabeling the etiology
of death (37). Physicians often do not recall the cause of
death and may confuse underlying cause of death with
mechanism of death (20). In addition, such data may suffer
from biases of ascertainment, whereby knowledge of a
patient’s prior medical conditions may affect physicians’
interpretations of cause of death. For example, a patient’s
presentation with a myocardial infarction may bias a physi-
cian to label subsequent death as cardiac, even when it may
not have been so. Similar to others’ ﬁndings, death certiﬁ-
cates had low sensitivity and speciﬁcity in our analysis.
Therefore, it is reasonable to conclude that death certiﬁcates
are an inaccurate representation of cause of death and hence
should not be used for outcome reporting. There is no
current consensus on the process of accurately determiningFigure 4
Cause of Death as Designated on Death Certiﬁcates
Compared With Chart Review
Cause of death as designated on death certiﬁcates is divided into cardiac and
noncardiac categories. These categories are further divided into those correlating
with cause of death as determined by chart review. Death certiﬁcates had
a sensitivity of 69% (95% conﬁdence interval [CI]: 52% to 86%), speciﬁcity of 46%
(95% CI: 26% to 66%), and an accuracy of 58% (95% CI: 45% to 72%).the cause of death, and questions on how the etiology of
death should be established and who will ascertain it
(hospital/healthcare professional performing the procedure
or an independent committee) remain unanswered.
There are also other issues related to public reporting.
Currently, there is no consensus on adjudicating death from
anoxic brain injury after cardiac arrest into cardiac versus
noncardiac death, especially if the patient underwent a
successful PCI. Similarly, PCI-related complications such as
bleeding or contrast-induced nephropathy may represent
patient frailty rather than a direct complication of PCI. In
our cohort, 4 patients had fatal bleeding; of these, only 1 was
related to access site complication. Excluding the 3 patients
with GI and intracranial bleeding would result in a lower
incidence of PCI-related death. Furthermore, in many cases,
a single cause of death cannot be identiﬁed due to ongoing
multiorgan failure. Lastly, current public health reporting
does not reward institutions that successfully treat high-risk
patients who were refused previously nor report institutions
that refuse PCI when it is indicated.
Study limitations. This is a single-center study and data
from a tertiary referral hospital may not apply across other
centers. Our study has a small sample size; however, our
ﬁndings appear to be consistent with other studies that have
assessed the accuracy of death certiﬁcates for determining
cause of death. A conservative approach to adjudication of
death as cardiac was made, and actual rates of cardiac death
after PCI may be lower.We acknowledge the lack of standard
deﬁnitions for several of the noncardiac causes of death across
different registries, but we have made an attempt to use
standard or common practice deﬁnitions wherever possible.
All outside hospital cardiac arrests and deaths were considered
as stent thrombosis and a PCI-relatedmortality; however, it is
possible that a portion of these patients died from arrhythmias
or other cardiac causes not related to PCI. Lastly, despite
making every effort to be objective, unintentional errors in
determining the exact cause of death may have occurred.
Conclusions
Public reporting of PCI outcomes will allow transparency,
help patients make informed decisions, and may be linked to
reimbursements. However, in its current form, this may lead
to risk avoidance and worse outcomes in high-risk patients.
Classiﬁcation of deaths into PCI-related and non–PCI-
related may be a better marker of operator performance and
quality of procedure. Death certiﬁcates have limitations and
are not ideal for public health reporting.
Acknowledgment
The authors thank Kathryn Brock for her editorial assistance.
Reprint requests and correspondence: Dr. Mehdi H. Shishehbor,
Cleveland Clinic Foundation, 9500 Euclid Avenue, J3-5, Cleve-
land, Ohio 44195. E-mail: shishem@ccf.org.
JACC Vol. 62, No. 5, 2013 Aggarwal et al.
July 30, 2013:409–15 Etiology of 30-Day Mortality After PCI
415REFERENCES
1. Centers for Medicare and Medicaid Services. Proposals for
improving quality of care during inpatient stays in acute care hospitals
in the ﬁscal year 2011. Notice of proposed rule making. Available at:
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/
AcuteInpatientPPS/downloads/FSQ09_IPLTCH11_NPRM041910.
pdf. Accessed April 1, 2012.
2. U.S. Department of Health and Human Services. Hospital Compare.
Available at: http://www.naph.org/Main-Menu-Category/Publications/
Quality/CMS-Quality-Data.aspx. Accessed April 1, 2012.
3. Werner RM, Asch DA. The unintended consequences of publicly
reporting quality information. JAMA 2005;293:1239–44.
4. Resnic FS, Welt FG. The public health hazards of risk avoidance
associated with public reporting of risk-adjusted outcomes in coronary
intervention. J Am Coll Cardiol 2009;53:825–30.
5. Califf RM, Peterson ED. Public reporting of quality measures what are
we trying to accomplish? J Am Coll Cardiol 2009;53:831–3.
6. Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of
public reporting for percutaneous coronary intervention with utilization
and outcomes among Medicare beneﬁciaries with acute myocardial
infarction. JAMA 2012;308:1460–8.
7. Moscucci M. Public reporting of PCI outcomes and quality of care: one
step forward and new questions raised. JAMA 2012;308:1478–9.
8. Apolito RA, Greenberg MA, Menegus MA, et al. Impact of the New
York State Cardiac Surgery and Percutaneous Coronary Intervention
Reporting System on the management of patients with acute myocar-
dial infarction complicated by cardiogenic shock. Am Heart J 2008;
155:267–73.
9. Adult percutaneous coronary intervention in the Commonwealth of
Massachusetts J-D, 2005. Available at: http://www.massdac.org/wp-
content/uploads/CompUseCriteria.pdf. Accessed April 1, 2012.
10. Peterson ED, Dai D, DeLong ER, et al., for the NCDR Registry
Participants. Contemporary mortality risk prediction for percutane-
ous coronary intervention: results from 588,398 procedures in the
National Cardiovascular Data Registry. J Am Coll Cardiol 2010;55:
1923–32.
11. Ellis SG, Shishehbor MH, Kapadia SR, et al. Enhanced prediction of
mortality after percutaneous coronary intervention by consideration of
general and neurological indicators. J Am Coll Cardiol Intv 2011;4:
442–8.
12. Resnic FS, Normand SL, Piemonte TC, et al. Improvement in mortality
risk prediction after percutaneous coronary intervention through the
addition of a “compassionate use” variable to the National Cardiovas-
cular Data Registry CathPCI dataset: a study from the Massachusetts
Angioplasty Registry. J Am Coll Cardiol 2011;57:904–11.
13. Holmes DR, Selzer F, Johnston JM, et al., for the NHLBI Registry.
Modeling and risk prediction in the current era of interventional
cardiology: a report from the National Heart, Lung, and Blood Insti-
tute Dynamic Registry. Circulation 2003;107:1871–6.
14. Singh M, Rihal CS, Lennon RJ, Garratt KN, Holmes DR Jr. A critical
appraisal of current models of risk stratiﬁcation for percutaneous
coronary interventions. Am Heart J 2005;149:753–60.
15. Rathore S, Grayson AD, Sastry S, et al., for the NWQIP Investigators.
Circumstances and mode of in-hospital death following 9,914
consecutive patients undergoing percutaneous coronary interventions in
the northwest of England. J Invasive Cardiol 2008;20:386–90.
16. Busk M, Maeng M, Kristensen SD, et al., for the DANAMI-2
Investigators. Timing, causes, and predictors of death after three years’
follow-up in the Danish Multicenter Randomized Study of Fibrinolysis
versus Primary Angioplasty in Acute Myocardial Infarction
(DANAMI-2) trial. Am J Cardiol 2009;104:210–5.
17. Stolker JM, Cohen DJ, Lindsey JB, Kennedy KF, Kleiman NS,
Marso SP. Mode of death after contemporary percutaneous coronaryintervention: a report from the Evaluation of Drug Eluting Stents and
Ischemic Events registry. Am Heart J 2011;162:914–21.
18. Cutlip DE, Windecker S, Mehran R, et al., for the Academic Research
Consortium. Clinical end points in coronary stent trials: a case for
standardized deﬁnitions. Circulation 2007;115:2344–51.
19. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/
ACCP/ATS/SIS International Sepsis Deﬁnitions Conference. Crit
Care Med 2003;31:1250–6.
20. Kircher T, Anderson RE. Cause of death: proper completion of the
death certiﬁcate. J Am Med Rec Assoc 1987;58:47–51.
21. National Cardiovascular Data Registry. NCDR CathPCI Registry v4.
4.Diagnostic catheterization and percutaneous coronary interven-
tion registry. Available at: https://www.ncdr.com/webncdr/cathpci/.
Accessed December 3, 2012.
22. Malenka DJ, O’Rourke D, Miller MA, et al., for the Northern New
England Cardiovascular Disease Study Group. Cause of in-hospital
death in 12,232 consecutive patients undergoing percutaneous trans-
luminal coronary angioplasty. Am Heart J 1999;137:632–8.
23. King SB 3rd. A valuable public option. J Am Coll Cardiol Intv 2010;3:
129–30.
24. Levy RI, Jesse MJ, Mock MB. NHLBI position on percutaneous
transluminal coronary angioplasty (PTCA). Am J Cardiol 1979;43:867.
25. Omoigui NA, Miller DP, Brown KJ, et al. Outmigration for coronary
bypass surgery in an era of public dissemination of clinical outcomes.
Circulation 1996;93:27–33.
26. Narins CR, Dozier AM, Ling FS, Zareba W. The inﬂuence of public
reporting of outcome data on medical decision making by physicians.
Arch Intern Med 2005;165:83–7.
27. Matheny ME, Ohno-Machado L, Resnic FS. Discrimination and
calibration of mortality risk prediction models in interventional cardi-
ology. J Biomed Inform 2005;38:367–75.
28. New York State Department of Health. Percutaneous coronary inter-
ventions (angioplasty) in New York State, 1995–1997 report. Available
at: http://www.health.ny.gov/statistics/diseases/cardiovascular/docs/
pci_1995-1997.pdf. Accessed April 1, 2012.
29. New York State Department of Health. Percutaneous coronary inter-
ventions (angioplasty) in New York State 2001–2003 report. Available
at: http://www.health.ny.gov/statistics/diseases/cardiovascular/docs/pci_
2001-2003.pdf. Accessed April 1, 2012.
30. Holmes DR Jr., Berger PB, Hochman JS, et al. Cardiogenic shock in
patients with acute ischemic syndromes with and without ST-segment
elevation. Circulation 1999;100:2067–73.
31. Hochman JS, Sleeper LA, Webb JG, et al., for the SHOCK Investi-
gators. Early revascularization in acute myocardial infarction compli-
cated by cardiogenic shock. N Engl J Med 1999;341:625–34.
32. Zumwalt RE, Ritter MR. Incorrect death certiﬁcation: an invitation to
obfuscation. Postgrad Med 1987;81:245–7. 250, 253–4.
33. Lenfant C, Friedman L, Thom T. Fifty years of death certiﬁcates: the
Framingham Heart Study. Ann Intern Med 1998;129:1066–7.
34. Lloyd-Jones DM, Martin DO, Larson MG, Levy D. Accuracy of
death certiﬁcates for coding coronary heart disease as the cause of death.
Ann Intern Med 1998;129:1020–6.
35. Harriss LR, Ajani AE, Hunt D, et al. Accuracy of national mortality
codes in identifying adjudicated cardiovascular deaths. Aust N Z J
Public Health 2011;35:466–76.
36. Daviglus ML, Liao Y, Greenland P, et al. Association of nonspeciﬁc
minor ST-T abnormalities with cardiovascular mortality: the Chicago
Western Electric Study. JAMA 1999;281:530–6.
37. Ravakhah K. Death certiﬁcates are not reliable: reviviﬁcation of the
autopsy. South Med J 2006;99:728–33.Key Words: cause of death - coronary intervention - mortality -
outcomes - public reporting - risk avoidance.
